Sensei Income Tax Expense vs Operating Income Analysis
| SNSE Stock | USD 0.60 0.08 15.38% |
Sensei Biotherapeutics financial indicator trend analysis is much more than just breaking down Sensei Biotherapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Sensei Biotherapeutics is a good investment. Please check the relationship between Sensei Biotherapeutics Income Tax Expense and its Operating Income accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sensei Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For information on how to trade Sensei Stock refer to our How to Trade Sensei Stock guide.
Income Tax Expense vs Operating Income
Income Tax Expense vs Operating Income Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Sensei Biotherapeutics Income Tax Expense account and Operating Income. At this time, the significance of the direction appears to have very week relationship.
The correlation between Sensei Biotherapeutics' Income Tax Expense and Operating Income is 0.2. Overlapping area represents the amount of variation of Income Tax Expense that can explain the historical movement of Operating Income in the same time period over historical financial statements of Sensei Biotherapeutics, assuming nothing else is changed. The correlation between historical values of Sensei Biotherapeutics' Income Tax Expense and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Income Tax Expense of Sensei Biotherapeutics are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Income Tax Expense i.e., Sensei Biotherapeutics' Income Tax Expense and Operating Income go up and down completely randomly.
Correlation Coefficient | 0.2 |
| Relationship Direction | Positive |
| Relationship Strength | Very Weak |
Income Tax Expense
Operating Income
Operating Income is the amount of profit realized from Sensei Biotherapeutics operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Sensei Biotherapeutics is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Most indicators from Sensei Biotherapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Sensei Biotherapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sensei Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For information on how to trade Sensei Stock refer to our How to Trade Sensei Stock guide.As of November 25, 2024, Selling General Administrative is expected to decline to about 12.9 M. In addition to that, Issuance Of Capital Stock is expected to decline to 855.00
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 670K | 219K | 144K | 136.8K | Depreciation And Amortization | 685K | 1.3M | 3.7M | 3.9M |
Sensei Biotherapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Sensei Biotherapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Sensei Biotherapeutics fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 1.2M | 21.4M | 153.2M | 118.4M | 74.4M | 67.9M | |
| Short Long Term Debt Total | 16.1M | 567K | 2.4M | 8.0M | 6.2M | 5.1M | |
| Other Current Liab | 125K | 916K | 1.1M | 331K | (929K) | (882.6K) | |
| Total Current Liabilities | 21.7M | 4.8M | 4.9M | 9.1M | 5.6M | 6.5M | |
| Total Stockholder Equity | (68.7M) | (56.4M) | 146.5M | 103.4M | 64.9M | 68.1M | |
| Property Plant And Equipment Net | 268K | 1.3M | 4.6M | 9.7M | 7.0M | 4.2M | |
| Net Debt | 15.8M | (16.0M) | (4.8M) | (9.8M) | (6.8M) | (6.5M) | |
| Retained Earnings | (92.3M) | (112.4M) | (149.2M) | (197.8M) | (231.9M) | (220.3M) | |
| Accounts Payable | 3.5M | 3.9M | 2.5M | 4.5M | 1.7M | 3.1M | |
| Cash | 251K | 16.6M | 7.2M | 17.8M | 13.0M | 10.2M | |
| Non Current Assets Total | 715K | 1.4M | 4.7M | 9.8M | 7.1M | 4.4M | |
| Cash And Short Term Investments | 251K | 16.6M | 147.6M | 17.8M | 65.8M | 45.6M | |
| Common Stock Shares Outstanding | 29.3M | 30.6M | 27.7M | 30.7M | 28.0M | 26.9M | |
| Liabilities And Stockholders Equity | 1.2M | 21.4M | 153.2M | 118.4M | 74.4M | 67.9M | |
| Non Current Liabilities Total | 48.2M | 73.0M | 1.8M | 5.9M | 3.8M | 3.6M | |
| Other Current Assets | 251K | 3.5M | 921K | 1.5M | 1.5M | 1.4M | |
| Other Stockholder Equity | (23.9M) | 56.0M | 296.0M | 302.2M | 297.0M | 165.4M | |
| Total Liab | 69.9M | 77.9M | 6.7M | 15.0M | 9.5M | 9.0M | |
| Net Invested Capital | (52.6M) | (55.9M) | 146.5M | 103.4M | 64.9M | 68.1M | |
| Property Plant And Equipment Gross | 268K | 1.3M | 5.8M | 11.2M | 8.8M | 5.0M | |
| Total Current Assets | 502K | 20.1M | 148.5M | 108.6M | 67.3M | 63.5M | |
| Non Current Liabilities Other | 620K | 138K | 149K | 67K | 60.3K | 57.3K | |
| Net Working Capital | (21.2M) | 15.2M | 143.7M | 99.5M | 61.6M | 54.5M | |
| Short Term Debt | 16.1M | 32K | 1.4M | 4.3M | 4.9M | 3.6M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Sensei Biotherapeutics is a strong investment it is important to analyze Sensei Biotherapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Sensei Biotherapeutics' future performance. For an informed investment choice regarding Sensei Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sensei Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For information on how to trade Sensei Stock refer to our How to Trade Sensei Stock guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sensei Biotherapeutics. If investors know Sensei will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sensei Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.19) | Return On Assets (0.27) | Return On Equity (0.45) |
The market value of Sensei Biotherapeutics is measured differently than its book value, which is the value of Sensei that is recorded on the company's balance sheet. Investors also form their own opinion of Sensei Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sensei Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sensei Biotherapeutics' market value can be influenced by many factors that don't directly affect Sensei Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sensei Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sensei Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sensei Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.